Trial
NCT04901676
Leronlimab in Moderately Ill Patients With COVID-19 Pneumonia
Phase IIISUSPENDEDSAFETYConfidence: MEDIUM
Sponsor
Hospital Israelita Albert Einstein
Collaborators
CytoDyn, Inc.
Condition
COVID-19 Pneumonia
Intervention
Leronlimab
Why stopped
Pending DSMB evaluation
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-04-15